These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11513351)

  • 21. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
    Mayeux R; Small SA; Tang M; Tycko B; Stern Y
    Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease.
    Kim KW; Jhoo JH; Lee JH; Lee DY; Lee KU; Youn JC; Youn JY; Woo JI
    Dement Geriatr Cogn Disord; 2002; 13(3):125-9. PubMed ID: 11893834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senile degeneration and cognitive impairment in chronic schizophrenia.
    Dwork AJ; Susser ES; Keilp J; Waniek C; Liu D; Kaufman M; Zemishlany Z; Prohovnik I
    Am J Psychiatry; 1998 Nov; 155(11):1536-43. PubMed ID: 9812114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impact of subcortical vascular and Alzheimer's disease pathology.
    Chui HC; Zarow C; Mack WJ; Ellis WG; Zheng L; Jagust WJ; Mungas D; Reed BR; Kramer JH; Decarli CC; Weiner MW; Vinters HV
    Ann Neurol; 2006 Dec; 60(6):677-87. PubMed ID: 17192928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
    Purohit DP; Davidson M; Perl DP; Powchik P; Haroutunian VH; Bierer LM; McCrystal J; Losonczy M; Davis KL
    Biol Psychiatry; 1993 Feb; 33(4):255-60. PubMed ID: 8471678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment in elderly patients with schizophrenia: age related changes.
    Harvey PD
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S78-85. PubMed ID: 11748791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
    Qiu WY; Yang Q; Zhang W; Wang N; Zhang D; Huang Y; Ma C
    Curr Alzheimer Res; 2018 Mar; 15(5):462-473. PubMed ID: 29110614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the rate of cognitive decline in aging and early Alzheimer disease.
    Adak S; Illouz K; Gorman W; Tandon R; Zimmerman EA; Guariglia R; Moore MM; Kaye JA
    Neurology; 2004 Jul; 63(1):108-14. PubMed ID: 15249619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing cognitive function in schizophrenics and patients with Alzheimer's disease.
    Mohs RC
    Schizophr Res; 1995 Sep; 17(1):115-21. PubMed ID: 8541244
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Cognitive stress test" may yield early clues of preclinical AD.
    Hotz RL
    Am J Alzheimers Dis Other Demen; 2001; 16(1):9-10. PubMed ID: 11416956
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduced neuronal activity and reactivation in Alzheimer's disease.
    Swaab DF; Lucassen PJ; Salehi A; Scherder EJ; van Someren EJ; Verwer RW
    Prog Brain Res; 1998; 117():343-77. PubMed ID: 9932420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.